Healthcare markets are full of gaps that go unnoticed until someone with the right vantage point decides to fill them. Christopher Ridgeway New Orleans based healthcare executive built his reputation by doing exactly that, transforming an identified shortage of comprehensive clinical testing into a specialty laboratory now serving providers across the country.
The story begins with observation rather than ambition alone. While working within the medical device industry, Ridgeway noticed that physicians often struggled to find a single laboratory partner capable of handling a truly broad menu of clinical services. Instead, they were forced to juggle multiple vendors for different testing needs, an inefficient arrangement that slowed diagnostics and complicated patient care. That gap became the motivating force behind Stone Clinical Laboratories.
Rather than offering a narrow slice of services, Ridgeway structured the laboratory around a wide-ranging clinical offering. Toxicology testing sits alongside early-stage cancer detection, giving physicians tools for both immediate clinical decisions and longer-term preventive screening. Pharmacogenetics, a field Ridgeway had already gained deep familiarity with through his prior General Manager role at a national pharmacogenetics laboratory, rounds out the menu by helping providers understand how individual patients metabolize medications. Pathology and general wellness testing further extend the lab’s reach into everyday clinical practice.
This breadth of service wasn’t accidental. It reflects Ridgeway’s conviction that a laboratory should function as a true partner to physicians rather than a transactional vendor. By consolidating so many testing categories under one roof, Stone Clinical Laboratories reduces the friction providers face when ordering diagnostics, while also giving patients faster access to results that inform their care.
The laboratory’s footprint includes facilities in Ridgeway’s hometown of New Orleans as well as Florida, positioning it to serve healthcare providers well beyond a single regional market. Combined with the medical device distribution capabilities carried over from Stone Surgical, the organization now operates as a single-source provider capable of supporting facilities nationwide with both equipment and specialty testing. For Ridgeway, the expansion of clinical testing access represents more than a business milestone. It’s a direct response to a problem he witnessed firsthand during his years in the field, and it continues to shape how the laboratory evolves its service offerings for physicians and patients alike.